MedTrace Logo

A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block

NCT04189198 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-04-28

No results posted yet for this study

Summary

Effect of 2%Articaine versus 5%bupivacaine in pt undergoing short duration surgery in upper limb

Conditions

  • Upper Limb Surgery
  • Hand Surgery

Interventions

DRUG

Articaine

Supraclavicular block with 30 ml articaine 2%

DRUG

Bupivacaine

Supraclavicular block with 30 ml bupivacaine 0.5%

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Galal Mo El kadi, Doctor · Professor

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-30
Primary Completion
2020-03-22
Completion
2020-03-27
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04189198 on ClinicalTrials.gov